mild-moderate benign prostatic hyperplasia
Conditions
Sponsors
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Eligibility
Sex/Gender
Male
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 40–80 years old; 2. diagnosed with BPH for more than 3 months; 3. syndrome differentiation in traditional Chinese medicine conforms to kidney yang deficiency; 4. abstain from medication for BPH for more than 6 months before the start of treatment; 5. IPSS score < 19 (mild-moderate BPH); 6. Qmax<15mL/s or average flow rate (Qave)<10ml/s; 7. with stable life signs; 8. voluntary participation in the study and sign informed consent prior to treatment.
Exclusion criteria
Exclusion criteria: 1. oliguria and anuria caused by bladder or prostate malignancy, urolithiasis, acute/chronic renal failure; 2. urinary dysfunction caused by neurogenic bladder, bladder neck fibrosis, and urethral stricture; 3. gonorrhea and urinary tract infection; 4. failure of invasive therapy for BPH; 5. local organs, muscles and nerves injured by pelvic operation or trauma; 6. abdominal aneurysms, hepatosplenomegaly, and serious cerebrovascular, cardiovascular, respiratory, digestive, hematological, or psychiatric diseases; 7. blood coagulation disorders or requiring administration of anticoagulant medication, such as Warfarin and Dabigatran; 8. cognitive dysfunction, psychosis, unable to cooperate with the examination and treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| International prostate symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean number of nightly urinations;Average flow rate (Qave);Prostate volume;Maximum urinary flow rate (Qmax); | — |
Countries
China
Contacts
Public ContactTao Zhang
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China
Outcome results
None listed